According to Soligenix's latest financial reports the company's current revenue (TTM) is $0.11 M. In 2022 the company made a revenue of $0.94 M an increase over the years 2021 revenue that were of $0.82 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.83 M | -11.55% |
2022 | $0.94 M | 15.12% |
2021 | $0.82 M | -65.07% |
2020 | $2.35 M | -49.04% |
2019 | $4.62 M | -11.67% |
2018 | $5.24 M | -3.52% |
2017 | $5.43 M | -48.01% |
2016 | $10.44 M | 19.16% |
2015 | $8.76 M | 24.5% |
2014 | $7.04 M | 118.45% |
2013 | $3.22 M | 2.53% |
2012 | $3.14 M | -58.96% |
2011 | $7.66 M | 293.44% |
2010 | $1.94 M | -30.84% |
2009 | $2.81 M | 21.89% |
2008 | $2.31 M | 83.59% |
2007 | $1.25 M | -45.6% |
2006 | $2.31 M | -22.27% |
2005 | $2.97 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $89.65 B | 76,612,534.48% | ๐บ๐ธ USA |
Pfizer PFE | $55.09 B | 47,076,265.69% | ๐บ๐ธ USA |
Sanofi SNY | $50.51 B | 43,163,170.93% | ๐ซ๐ท France |
Onconova Therapeutics ONTX | $0.22 M | 93.11% | ๐บ๐ธ USA |
Athersys ATHX | $0.08 M | -31.64% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $16.00 B | 13,674,288.40% | ๐ฎ๐ฑ Israel |
Cleveland BioLabs
CBLI | $0.63 M | 439.90% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $1.15 B | 989,056.53% | ๐บ๐ธ USA |